Omentoplasty and omentopexy post-pelvic lymph node dissection in surgical management of gynecological tumors

Abstract

Background: Lymphadenectomy is staging procedure used in studied cases with pelvic gynaecological cancer, however, pelvic lymphadenectomy was associated with morbidities like lymphedema & lymphocysts, Omentoplasty-omentopexy has been utilized for prevention of lymphocysts that develop following pelvic lymphadenectomy. Patients and methods: This study is randomized controlled trial. 41 consecutive patients who were candidates for pelvic lymphadenectomy during radical hysterectomy for cancer cervix or endometrium were enrolled in this research & were allocated to 2 groups. Intervention group (Omentoplasty-Omentopexy (A) group) included twenty-one patients who underwent omentoplasty-omentopexy. Control group (B) group included twenty patients who did not underwent omentoplasty-omentopexy. The two groups were compared regarding development of lymphocyst. The study was done at National Cancer Institute, Cairo University from January 2020 to June 2021. Results: Forty-one consecutive studied cases were enrolled in this research from January 2020 to June 2021. With an average age 58.9±12.4 years,no statistically significant variation between the Omentoplasty-Omentopexy (A) & control group (B) regarding tumor site and histopathologic tumor types and tumor grade. No significant difference was found regarding primary tumor location either endometrial or cervical and its effect on post operative complications.